7 .
diabetic retinopathy ( eye background changes ) .
at the end of the double-blind study , patients could enter a long-term open-label extension study for a total duration of up to 2 years .
the following side effects listing is based on reports from clinical trials with Betaferon ( table 1 ) and from side effects reported on the marketed product ( table 2 ) .
reproductive system and breast disorders
hypersensitivity to the active substance or to any of the excipients .
6.1 List of excipients
however , no proper explanation for these findings in women has been identified .
read the package leaflet before use .
check that the cap of the vial is still intact .
the Committee considered the referral made under article 31 of Directive 2001 / 83 / EC , as amended , for medicinal products containing BICALUTAMIDE 150 mg .
5 .
in the virologic failures of the ARTEMIS trial no cross-resistance with other PIs was observed .
6 .
respiratory , thoracic and mediastinal disorders
how to store Insulin Human Winthrop Rapid 6 .
DATE OF FIRST AUTHORISATION / RENEWAL OF AUTHORISATION
Aranesp should also be used with caution in those patients with sickle cell anaemia or epilepsy .
strength
- lowers blood glucose and promotes anabolic effects as well as decreasing catabolic effects ,
50 q.d .
powder Sodium carbonate , anhydrous mannitol Sodium hydroxide Hydrochloric acid
the maximum recommended dosing frequency is once per day .
medicinal product subject to medical prescription
1 vial :
3 .
2 .
Whatever the cause is , due to muscle and blood vessel changes not enough blood stays in the penis to make it hard and keep it hard .
4 .
children Clearance adjusted for body weight is higher in children than in adults with the highest values in children under five years .
dose changes in the maintenance phase of treatment should not be made more frequently than every two weeks .
name OF THE MEDICINAL PRODUCT
this suggests that a second booster dose of pertussis vaccine is warranted in children aged 5-7 years who have previously been vaccinated following this particular schedule .
Removing the needle
you may find that your vision is blurred for a time just after you use Emadine .
factors increasing the susceptibility to hypoglycaemia require particularly close monitoring and may necessitate dose adjustment .
solvent vial contains 1.5 ml of a 13 % w / w solution of ethanol 95 % in water for injections ( fill volume :
film-coated tablet
dermatitis , dry skin , erythema , pruritus
SP Europe , 73 , rue de Stalle , B-1180 Bruxelles , Belgium
further INFORMATION
10 method of administration
Baxter AG A-1221 Vienna Austria
Tél . : + 34 93 470 79 40
• Your skin becomes more sensitive to sunlight or ultraviolet ( UV ) light when taking Ciprofloxacin Bayer .
common : diplopia , visual disturbance , photophobia
in study GS-99-907 , 550 treatment-experienced patients were treated with placebo or tenofovir disoproxil 245 mg ( as fumarate ) for 24 weeks .
for environmental and safety reasons , used as well as unused and out of date patches must be discarded or returned to the pharmacy for disposal .
system organ class
in case of overdose , general supportive measures and symptomatic treatment should be administered .
due to intra-patient variability , occasional individual haemoglobin values for a patient above and below the desired haemoglobin level may be observed .
( lipodystrophy ) .
in postmarketing , serious allergic reactions including anaphylaxis have been reported very rarely following Humira administration .
6 .
Portugal
for further instructions on dilution with glucose 50 mg / ml ( 5 % ) solution prior to infusion see section 6.6 .
9 .
for the 60 re-treatments on study , the ORR was 38 % ( CI95 % 26 % – 51 % ; 10 % CR , 28 % PR ) with a projected median TTP for responding patients of 17.8 months ( range 5.4 – 26.6 ) .
film-coated tablet
administration of Kaletra with a high fat meal ( 872 kcal , 55.8 % from fat ) increased lopinavir AUC and Cmax by 96 % and 43 % , respectively , for soft capsules , and 130 % and 56 % , respectively , for oral solution .
dialysis patients converting from once weekly to once every other week dosing ng with Nespo should initially receive a dose equivalent to twice the previous once weekly dose .
Ir-Renju Unit Tel : + 44 ( 0 ) 28 7086 8733
Thiomersal
72 31
2001
test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur .
concomitant agents included angiotensin converting enzymes inhibitors , angiotensin-II antagonists , nonsteroidal anti-inflammatory medicinal products and diuretics .
the aim of the loading dose is to reach ‘ steady state ’ ( stable ) blood levels .
other information about CYANOKIT :
29 Take special care with Viread
gastrointestinal effects were observed in the dog at systemic exposure levels equivalent to or less than the clinical exposure at the recommended dose .
do not massage the injection site .
sodium oxybate is not recommended during pregnancy .
subcutaneous use .
- Patients with a history of hypersensitivity to natural or recombinant interferon-ß or to any
16 .
EMEA / CPMP / SWP / 2775 / 99
never turn the dosage selector after injection button has been pulled out .
Domaniewska 50 C PL – 02 672 Warszawa Tel . : + 48-22 549 15 00
one ampoule contains 5 ml solvent ( water for injections with benzyl alcohol and benzalkonium chloride as preservatives ) .
II
clinical PARTICULARS
if you become pregnant during therapy with Irbesartan Krka , please inform and see your doctor without delay .
polysorbate 80 citric acid hydrochloric acid sodium chloride .
5 .
prepare the dose just before you intend to inject it and use it immediately .
• to monitor the performance of the Agency and the parts of the system for which it is responsible to make sure that the performance is of high quality ; and if it is not , to take steps to Bring it up to standard 8 To carry out those tasks successfully , the Board concluded that it should :
Malta Actavis Ltd , Tel : + 356023679641
the premix is mixed into pig feed by an authorised feed Mill and the resulting “ medicated feeding stuff ” is then distributed to the farmer to treat a large number of pigs .
20 mg
no dosage adjustment is necessary for either medicinal product .
0.3 0.4 0.5 0.4 0.5 0.5 0.5
capsule Oral use capsule Oral use capsule Oral use Oro-dispersible tablet Oral use Oro-dispersible tablet Oral use Oro-dispersible tablet Oral use Oro-dispersible tablet Oral use
caution must be taken in any patient with a history of seizures .
Table 4 ACR Responses in RA Study V ( percent of patients )
accidental ingestion of nitisinone by individuals eating normal diets not restricted in tyrosine and Phenylalanine will result in elevated tyrosine levels .
treatment of porcine proliferative Enteropathy caused by Lawsonia intracellularis .
you may need to read it again .
Diovan 80 mg
- The solvent is water for injection .
it explains how the Committee for Medicinal Products for Human Use ( CHMP ) assessed the studies performed , to reach their recommendations on how to use the medicine .
lactose monohydrate Microcrystalline cellulose croscarmellose sodium Hypromellose silicon dioxide Magnesium stearate
after several years in general veterinary Practice in the United Kingdom and Canada , Dr JONES joined the pharmaceutical industry in the animal health sector .
20 – 40
9 .
LABELLING
no significant pharmacokinetic or pharmacodynamic interactions were observed when irbesartan was coadministered with warfarin , a medicinal product metabolised by CYP2C9 .
nervous disease ( diabetic autonomic neuropathy ) ,
Dynepo has no or negligible influence on the ability to drive and use machines. ic
no dosage adjustment is necessary in female patients .
PROHIBITION OF SALE , SUPPLY AND / OR USE
if you have the impression that the effect of IntronA is too strong or too weak , talk to your doctor or pharmacist .
14 tablets 28 tablets
the patient information pack should be provided in both a form of patient information booklet and audio-CD that contain following key elements : • patient information leaflet • How to prepare for Lucentis treatment • which are the steps following treatment with Lucentis • Key signs and symptoms of serious adverse events • When to seek urgent attention from the health care provider
is in the dose window .
* each ml of concentrate contains 1 mg of clofarabine .
Tel . : + 36 1 236 3800
the recommended dose is one 150 mg film-coated tablet once a month .
very common ( occurring in more than 1 in 10 patients ) : • chills
Pharmacodynamic properties
how RotaTeq IS GIVEN .
the absolute bioavailability of subcutaneously administered interferon beta-1b was approximately 50 % .
4 .
MARKETING AUTHORISATION NUMBER ( S )
100 IU / ml
Germany
BATCH
6 .
possible SIDE EFFECTS
possible SIDE EFFECTS
as the efficacy and safety of Intrinsa have not been evaluated in studies of longer duration than 1 year , it is recommended that an appraisal of the treatment is undertaken every 6 months .
13 .
taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription .
2 For subcutaneous administration only .
Bayer HealthCare AG D-51368 Leverkusen Germany
- sympathomimetic medicines ( such as epinephrine &#91; adrenaline &#93; or salbutamol , terbutaline used to
Karvezide has been rarely associated with symptomatic hypotension in hypertensive patients without other risk factors for hypotension .
5.3 Preclinical safety data
hypoglycaemia is the most frequent undesirable effect of insulin therapy that a patient with diabetes may suffer .
no data are available in patients with a creatinine clearance below 10 ml / min .
you should contact your doctor for advice on driving if :
what ADROVANCE is and what it is used for Before you take ADROVANCE How to take ADROVANCE Possible side effects How to store ADROVANCE Further information
cardiovascular system :
6.5 Nature and contents of container
Dispersible Tablet
CONDITIONS OF THE MARKETING AUTHORISATION
however , 5-ALA induced PPIX formation is significantly higher in malignant tissue than in normal brain .
Pimecrolimus
based on the results of clinical trials , in which data are available for 6 months of treatment , it is recommended that patients be treated with Viraferon in combination with ribavirin for 6 months. t uc
24 symptoms persist or worsen , or suicidal ideation is identified , it is recommended that treatment with Viraferon be discontinued , and the patient followed , with psychiatric intervention as appropriate .
talk about your insulin needs with your doctor and nurse .
Infanrix penta -1-
tn
ed iron , folic acid or vitamin B12 reduce the effectiveness of erythropoiesis stimulating agents and should therefore be corrected .
it is supplied in CARTONS containing 10 glass vials .
0.4 0.4
ROUTE ( S ) OF ADMINISTRATION
ribavirin therapy is contraindicated in women who are pregnant .
61 D-81673 München Germany
statement OF ACTIVE SUBSTANCE
further information
the most commonly reported side effects are nausea ( feeling sick , 6 % ) and headache ( 6 % ) .
elimination The terminal half-life is determined by the rate of absorption from the subcutaneous tissue .
6 .
4.6 Pregnancy and lactation
information FOR THE USER
all of the children received two doses of Ambirix six months apart .
58 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND IMMEDIATE PACKAGING
1 .
like all medicines , Insuman Comb 50 can cause side effects , although not everybody gets them .
studies in animals have
Latvia
19.11.2008
BATCH NUMBER
Hypromellose Macrogol 8000 Talc Titanium dioxide .
load the dose
unchanged insulin glargine and degradation products are also present in the plasma .
6 .
clinical trials in paediatric patients with chronic hepatitis C :
5 .
ADARTREL
do not use after the expiry date which is stated on the carton after EXP :
the most frequently reported adverse reactions with lacosamide treatment were dizziness , headache , nausea and diplopia .
1 334 000
4.1 Therapeutic indications
fondaparinux should be used with caution in elderly patients ( see section 4.2 ) .
manufacturer Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg Germany
bioavailability was reduced by approximately 75 % when Bondronat tablets were administered 2 hours after a standard meal .
hypoglycaemia , in general the most frequent undesirable effect of insulin therapy , may occur if the insulin dose is too high in relation to the insulin requirement .
the Mutual Recognition Procedure started on 18 June 2003 .
dose limiting toxicities were observed in 36 % ( 5 of 14 ) patients receiving 6 doses of 80 micrograms / kg / day administered intravenously over 2 weeks ( 3 doses preceding and three doses following myeloablative therapy ) .
6.2 Incompatibilities
tell your doctor immediately if you experience :
Glaxo Wellcome , S. A .
because of
Vc
other symptoms noted include extrapyramidal symptoms , dysarthria , ataxia , aggression , dizziness , weakness , hypertension and convulsion .
it belongs to the family of hormones called gonadotrophins , which are involved in the normal control of reproduction .
the major circulating metabolite is the 10-N-glucuronide , which does not pass the blood brain barrier .
30.2 ( 256 / 848 ) 26.1 , 34.2
the calculated amount of interferon for the appropriate dose then is withdrawn from the vial ( s ) , added to 100 ml of 9 mg / ml ( 0.9 % ) sodium chloride solution for injection and administered over 20 minutes .
hepatic insufficiency :
Danmark Bayer A / S Tlf : + 45-45 23 50 00 Deutschland Bayer vital GmbH Tel : + 49- ( 0 ) 214-30 513 21 Eesti UAB Bayer Esti filiaal Tel : + 372 655 85 65 Ελλάδα Bayer Ελλάς ΑΒΕΕ Τηλ : + 30-210-618 75 00 España Química Farmacéutica Bayer S. L .
the dark purple colour of the solution together with the amber vial makes a visual check for particulates impossible .
Magyarország Alkotás u .
in order to minimise the risks of opioid-related undesirable effects and to identify the effective dose , it is imperative that patients be monitored closely by health professionals during the titration process .
the absorption is not affected by food .
common Uncommon
Slovenija Alcon d.o.o. + 386 1 422 5280
20
other Patients known to be CYP2C9 poor metabolisers should be treated with caution ( see section 5.2 ) .
they stop automatically after the pre-set dose has been delivered .
the primary endpoint was the proportion of patients who were alive and free of Invasive ventilator support .
with twice weekly doses , it is anticipated that steady-state concentrations are approximately twice as high as those observed after single doses .
8 .
100 % ( 95 % CI : - 1858.0 ; 100 ) , 100 % ( 95 % CI :
weight increased Weight decreased Blood creatinine increased , blood creatine phosphokinase increased , blood lactate dehydrogenase increased , blood alkaline phosphatase increased
dosing should be titrated as necessary to maintain the haemoglobin target. ct
use in pregnancy There are no adequate data from the use of this medicinal product in pregnant woman .
caution should be exercised in patients with elevated ALT and / or AST , in patients with signs and symptoms of hepatic impairment , in patients with pre-existing conditions associated with limited hepatic functional reserve , and in patients who are being treated with potentially hepatotoxic medicines .
79 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
what REGRANEX IS AND WHAT IT IS USED FOR
do not take Procoralan if you are pregnant or planning a pregnancy ( see “ Do not take Procoralan ” ) .
EXP
hepatic impairment ( see 5.2 Pharmacokinetic properties ) .
common :
Poly ( dimethylsiloxane , trimethylsilyl silicate ) -copolymerisate , Povidone K90 , sodium metabisulphite ( E223 ) , ascorbyl palmitate ( E304 ) and DL-α -tocopherol ( E307 ) .
15 .
- If any of the side effects gets serious , or if you notice any side effects not listed in this leaflet ,
these cases include fatal fulminant hepatitis / hepatic failure .
84 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
in a mass balance study using radiolabelled material , 78 % of the administered dose was recovered from the urine based on total radioactivity , whilst urinary recovery of unchanged daptomycin was approximately 50 % of the dose .
common
insulin Human Winthrop Basal 100 IU / ml suspension for injection in a cartridge
once a syringe is opened it should only be used to continue the treatment course in the same animal .
1 ml suspension contains 100 IU ( 3.5 mg ) of insulin human ( rDNA ) ( 50 % as soluble insulin and 50 % as isophane insulin ) .
why has Orgalutran been approved ?
7 % * *
5 .
sleep disorder , anxiety neurotoxicity , Tremor , neuralgia , Hypersensitivity reaction
correction phase :
clinical response rates in patients experiencing somnolence were 60 % on duloxetine and 30 % on placebo .
MARKETING AUTHORISATION HOLDER
discard
package size
7 In two long term clinical studies conducted in adults , persistence of anti-HAV and anti-HBs antibodies has been proven up to 60 months following the initiation of a primary vaccination course of Twinrix Adult in the majority of vaccinees .
7 Westferry Circus , Canary Wharf , London E14 4HB , UK Switchboard :
possible systemic effects include adrenal suppression , growth retardation in children and adolescents , decrease in bone mineral Density , cataract and glaucoma ( see 4.4 ‘ Special warnings and precautions For Use ’ ) .
5 .
the dose for SUSTIVA may need to be increased or decreased if you are also taking certain medicines ( see Taking other medicines ) .
a special pack with patches of four different strengths is available to help when starting treatment .
CONDITIONS OF THE MARKETING AUTHORISATION
other SPECIAL WARNING ( S ) , IF NECESSARY
Puregon 150 IU / 0,5 ml solution for injection follitropin beta
the active ingredient in your tablets , Doxazosin , belongs to a group of medicines known as alpha-blockers .
dose changes should not exceed increases or decreases of 10 mg / kg twice daily every two weeks .
in patients with YMDD variant HBV , 18 / 39 ( 46 % ) had improvements in necroinflammatory activity and 9 / 39 ( 23 % ) had worsening .
if you have been told by your doctor that you have an intolerance to some sugars , such as sorbitol , contact your doctor before taking this medicinal product .
6.3 Shelf life
nr
statement OF ACTIVE SUBSTANCE ( S )
20 % higher for Cmax and approx .
following oral administration of Irbesartan Hydrochlorothiazide Winthrop , the absolute oral bioavailability is 60-80 % and 50-80 % for irbesartan and hydrochlorothiazide , respectively .
statement OF THE ACTIVE SUBSTANCE ( S ) AND OTHER ingredient ( S )
Dispersible Tablet
1 dose ( 0.5 ml ) :
84 10 .
11 .
1 .
lipid lowering MEDICINAL PRODUCTS hMG Co-A reductase Inhibitors Atorvastatin / Efavirenz ( 10 mg once daily / 600 mg once daily )
in patients whose manic episode has responded to olanzapine treatment , olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder ( see section 5.1 ) .
the rate of pregabalin absorption is decreased when given with food resulting in a decrease in Cmax by approximately 25-30 % and a delay in tmax to approximately 2.5 hours .
direct sunlight :
medicinal product subject to medical prescription .
France Fort Dodge Santé Animale Tel : + 33 ( 0 ) 2 47 74 89 89
d .
Prevenar suspension for injection in pre-filled syringe Pneumococcal saccharide conjugated vaccine , adsorbed
96.3
oral use Oral use Oral use
vial LABEL
cutaneous use
read the package leaflet before use .
interaction not studied .
contents BY WEIGHT , BY VOLUME OR BY UNIT
check each time you inject yourself .
if not used immediately , in-use storage and conditions are the responsibility of the user .
two dosing regimens can be recommended :
Table 10 :
- autoimmune hepatitis ; or history of autoimmune disease ; immunosuppressed transplant
( 43-1 ) 711 72 46 73 Fax :
QUALITATIVE AND QUANTITATIVE COMPOSITION
the use of memantine in pregnant women is not recommended .
EU / 1 / 07 / 398 / 008 1 x 15 ml :
pharmacological PROPERTIES
it is recommended that patients should be evaluated at least every second year in the 4-year period after initiation of treatment with Rebif and a decision for longer term treatment should then be made on an individual basis by the treating
the absolute bioavailability of lopinavir co-formulated with ritonavir in humans has not been established .
qualified pharmacist from the University of Uppsala Faculty of pharmacy .
Additionally , the pharmacokinetics of Enbrel in rheumatoid arthritis patients , ankylosing spondylitis and plaque psoriasis patients are similar .
PHARMACEUTICAL Form
concurrent administration of potentially nephrotoxic medicines should be avoided as there might be an increased risk of renal toxicity .
th An overdose of the product can result in a moderate swelling at the injection site that can persist for 2- 3 weeks .
1 x 50
a sustained haemoglobin level of greater than 12 g / dl ( 7.5 mmol / l ) should be avoided ; guidance for appropriate dose adjustment for when haemoglobin values exceeding 12 g / dl ( 7.5 mmol / l ) are observed are described below .
growth parameters were decreased at high doses .
300
lot :
clinical PARTICULARS
13 .
infusion reactions occurred in 15 % patients following the first infusion of rituximab and 5 % in placebo patients .
subcutaneous use
16 172 000 1 183 000 1 161 000
Cmin
17 ANNEX II
solution for injection in a pre-filled syringe
if you take more ADARTREL than you should someone who has taken an overdose may experience ; feeling or being sick , dizziness ( or spinning sensation ) , feeling drowsy , fatigue ( mental or physical tiredness ) , stomach pain , fainting or nervousness .
provisions
injection site inflammation , injection site reaction , fatigue , rigors , fever § , influenza-like symptoms § , malaise , irritability
121 2 .
survival and tumour progression have been examined in five large controlled studies involving a total of 2833 patients , of which four were double-blind placebo-controlled studies and one was an open- label study .
pruritus :
change on multiple dosing over 12 weeks ( dosing every week or every two weeks ) .
Pegasys Combination Therapy
BATCH NUMBER BATCH { number }
there is no experience regarding the administration of Kinzalmono in patients with recent kidney transplantation .
Sandoz GmbH , Biochemiestr .
( n = 122 )
do not mix with any other immunological product except the solvent supplied .
ciclosporin should be progressively discontinued over 4 to 8 weeks and the Rapamune dose should be adjusted to obtain whole blood trough levels of 12 to 20 ng / ml ( chromatographic assay ; see Therapeutic drug monitoring ) .
important information about some of the ingredients of OSSEOR :
information IN BRAILLE
not applicable
as with all injectable vaccines , appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the vaccine .
4.6 Pregnancy and lactation
use an alcohol wipe to clean it .
8 .
the seroprotection rates , seroconversion rates and seroconversion factors for anti-haemagglutinin ( anti-HA ) antibody at day 42 ( post dose 2 ) and day 180 ( persistence ) were as follows :
therapy with pioglitazone should not be initiated in patients with increased baseline liver enzyme levels ( ALT &gt; 2.5 X upper limit of normal ) or with any other evidence of liver disease .
name OF THE MEDICINAL PRODUCT
21 Characteristics in patients
clinical manifestations of NMS are hyperpyrexia , muscle rigidity , altered mental status , and evidence of autonomic instability ( irregular pulse or blood pressure , tachycardia , diaphoresis , and cardiac dysrhythmia ) .
lithium :
2 mg / ml
do not freeze .
do NOT rub the injection site .
the total exposure to ADENURIC in phase 3 pivotal studies and long-term extension studies is greater than 2700 patient-years .
L01BC treatment of metastatic colorectal cancer
after three to four weeks of treatment , the dose may be increased to 7.5 mg twice daily depending on the therapeutic response .
name OF THE MEDICINAL PRODUCT
8 .
contains lactose monohydrate and soya Lecithin .
&#91; to be completed nationally &#93;
general disorders and ADMINISTRATIVE site conditions Metabolism and nutrition disorders
384 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
PHARMACEUTICAL FORM AND CONTENTS
1 single use pre-filled syringe
366 354 350 308 300
Liprolog 100 U / ml solution for injection in vial ( insulin lispro )
keep the pre-filled pen in the outer carton in order to protect from light .
instructions ON USE
- your blood sugar levels are almost normal or are unstable ,
powder for solution For intramuscular use for injection
treatment should be initiated by and remain under the guidance of a physician experienced in the management of opioid therapy in cancer patients .
BATCH NUMBER
34 Take one tablet once a week
Τηλ : + 30 210 68 82 100 ro
may become too low ( hypoglycaemia ) .
45 Poplar Road Parkville VIC 3052 Australia
14 .
9 / 9
Tel : + 420 221 016 111
film-coated tablets
compulsive shopping , delusion , Hypersexuality , libido disorder , paranoia , pathological gambling
do not freeze. lp
the oedema rates for comparator groups ( sulphonylurea , metformin ) were 2 – 5 % .
Loratadin von ct
subcutaneous use is preferable in patients who are not receiving haemodialysis to avoid the puncture of peripheral veins. ed
8 .
25 / 50
during the marketing of Azomyr , cases of severe allergic reactions ( difficulty in breathing , wheezing , itching , hives and swelling ) and rash have been reported very rarely .
4.1 Therapeutic indications
Ísland Icepharma hf .
Boehringer Ingelheim
if you have Crohn ’ s disease you will first be given other medicines .
bleeding is most common at the arterial access site in patients undergoing percutaneous arterial procedures .
Polska Boehringer Ingelheim Sp. zo. o .
Committee FOR PROPRIETARY MEDICINAL PRODUCTS ( CPMP ) SUMMARY INFORMATION ON A REFERRAL OPINION FOLLOWING AN ARBITRATION PURSANT TO ARTICLE 30 OF DIRECTIVE 2001 / 83 / EC , FOR
4.8 Undesirable effects
this regresses during the course of continued therapy .
it contains the active substance filgrastim .
always vary the sites you inject , to avoid lumps ( see 5 Possible side effects ) .
expiry DATE tn
this Fc component contains the hinge , CH2 and CH3 regions but not the CH1 region of IgG1 .
response or were intolerant to infliximab were randomised to receive either 160 mg Trudexa at week 0 and 80 mg at week 2 or placebo at weeks 0 and 2 .
patients should brush their teeth thoroughly twice daily and have regular dental examinations .
what is TESLASCAN used for ?
statistically significantly better than patients treated with placebo plus standard of care ( p &lt; 0.001 ) .
each hard capsule of
other information about Busilvex :
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
pregnancy and breast-feeding There is not much experience with NeoRecormon in pregnant women or women who are breast- feeding .
taking a MAOI together with many prescription medicines , including XERISTAR , can cause serious or even life-threatening side effects .
whilst studies in rats and mice have not produced any evidence of teratogenic effect , the safety during pregnancy and lactation has not been established in pigs .
a marked change in glycaemic control may cause temporary visual impairment , due to temporary alteration in the turgidity and refractive index of the lens .
5 .
3 .
- If you or any member of your family have glucose-6-phosphate dehydrogenase deficiency ( a
however this was considered counterproductive , since the shorter time frame would not allow sufficient time for the efficient preparation of assessment reports and the necessary participation of experts at intervening plenary meetings of the CVMP .
do not freeze .
20mg
7 .
mean volume of distribution at steady state was 196 ml / kg in paediatric patients versus 159 ml / kg in adults .
3 increased serum transaminases should have his / her liver function tests repeated within 48 hours .
Comtan is used together with levodopa to treat Parkinson ’ s disease .
-the Committee agreed that the efficacy of terfenadine containing medicinal products is considered similar to the other NSAHs .
5 .
- If you develop symptoms of a severe allergic reaction ( such as difficulty in breathing , wheezing , or
European PUBLIC ASSESSMENT REPORT ( EPAR )
9.9 ( 44 / 446 )
Renagel treatment should be re- evaluated in patients who develop severe constipation or other severe gastrointestinal symptoms .
Antimycotics for systemic use-triazole derivatives , ATC code :
6 .
endocrine disorders
renal impairment In an oral single dose ( 200 mg ) study in subjects with normal renal function and mild ( creatinine clearance 41-60 ml / min ) to severe ( creatinine clearance &lt; 20 ml / min ) renal impairment , the pharmacokinetics of voriconazole were not significantly affected by renal impairment .
Κύπρος Pfizer Hellas A. E .
Bayer AG 51368 Leverkusen Germany
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
individual responsiveness must be considered when treatment is initiated .
EMEA Work programme 2001-2002
Optimark should only be administered by physicians experienced in clinical MRI Practice .
1 %
if you do not respond to glucagon treatment , you will have to be treated in a hospital .
5 .
common
insulin Human Winthrop Basal is injected subcutaneously 45 to 60 minutes before a meal .
however , MPA C max was decreased by 40 % in the presence of food .
10 6
the following information is intended for medical or healthcare professionals only :
pull the plunger out until the black line on the plunger corresponds to your cat ´ s bodyw eight in kilogram s .
● gently tap the vial of Fuzeon to loosen the powder .
patients who take Kivexa must be given the special alert card that summarises the key safety information about the medicine .
hydrochlorothiazide crosses the placental but not the blood-brain barrier , and is excreted in breast milk .
it is therefore recommended that the diabetic patients carry some sugar lumps , sweets , biscuits or sugary fruit juice . • Severe hypoglycaemic episodes , where the patient has become unconscious , can be treated by glucagon ( 0.5 to 1 mg ) given intramuscularly or subcutaneously by a person who has received appropriate instruction , or by glucose given intravenously by a medical professional .
there is no safety data from post-marketing experience with INTANZA .
dermal infections ( pyoderma – Superficial and deep , wounds , abscesses ) caused by susceptible strains such as Staphylococci , E. coli , Proteus mirabilis .
when the injection has been administered the needle safety guard will cover the needle when releasing the plunger .
during use :
approximately 70 % of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites .
4.4 Special warnings and special precautions for use hypotension ACE inhibitors may cause a fall in blood pressure .
if bone marrow remission has not occurred by day 50 , dosing must be discontinued .
conjunctivitis
if the haemoglobin exceeds 12 g / dl ( 7.5 mmol / l ) , a dose reduction should be considered .
the patient ’ s ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia from glimepiride or , for example , as a result of visual impairment .
common : injection site reactions Uncommon : injection site urticaria Not known : injection site inflammation , injection site swelling , injection site pain , injection site pruritus , injection site erythema .
the dose of Zestril should be increased : • by increments of no greater than 10 mg • At intervals of no less than 2 weeks • To the highest dose tolerated by the patient up to a maximum of 35 mg once daily .
reported bleeding events include : anaemia or drop in the haemoglobin value without obvious source of bleeding , bruising , bleeding from puncture sites , nose bleeding , blood in urine , gastrointestinal bleeding , vaginal bleeding , Rectal bleeding , pulmonary haemorrhage , bleeding into chest space and around the heart following surgery , bleeding into the brain .
since hypotension may occur during MabThera infusion , consideration should be given to withholding anti-hypertensive medications 12 hours prior to the MabThera infusion .
no studies on the effects on the ability to drive and use machines have been performed .
B .
6 .
( 17.9 ) ( 21.0 ) ( 13.6 )
9 .
immune system disorders
Enalapril , which crosses the placenta , has been removed from the neonatal circulation by peritoneal dialysis with some clinical benefit , and theoretically may be removed by exchange transfusion .
please use as follows :
in the same study , a 25 % increase in the AUC of theophylline ( marker of cytochrome P450 1A2 activity ) was observed , demonstrating that Pegasys is an inhibitor of cytochrome P450 1A2 activity .
MARKETING AUTHORISATION HOLDER
Sverige Merck Sharp &amp; Dohme ( Sweden ) AB Tel : + 46 ( 0 ) 8 626 1400 medicinskinfo @ merck. com
the following data are findings from studies performed with vildagliptin or metformin individually .
three Globeside Business Park Fieldhouse Lane Marlow Bucks SL7 1HZ- UK Tel : + 44 1628 646400
do not take VFEND : -If you are allergic to voriconazole or any of the other ingredients of VFEND
10 .
maintenance of clinical remission was evaluated in CHARM .
50 ml 100 ml 200 ml
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
4.3 Contraindications
the European Medicines Agency ( EMEA ) will review any new information which may become available every year and this SPC will be updated as necessary .
few cases of coagulopathic disorders such as increased D-dimer and consumptive coagulopathy have been reported .
what Docetaxel Winthrop concentrate vial contains
your doctor will perform appropriate laboratory tests to make sure that you have adequate Factor VIII levels .
docetaxel Winthrop is supplied as single-dose vials .
other
it is not known whether maraviroc is secreted into human milk .
• shortened time to tumour progression in patients with advanced head and neck cancer receiving radiation therapy when administered to target a haemoglobin of greater than 14 g / dl ( 8.7 mmol / l ) , ESAs are not indicated for use in this patient population .
the relevance of this finding is unknown .
genotype 2 , 3
1.2 ml
subcutaneous administration cannot be substituted for intramuscular administration .
( see ‘ precautions ’ , haemorrhage ) .
irbesartan is mainly metabolised by CYP2C9 and to a lesser
8 .
symptomatic hypotension , especially after the first dose of Pritor , may occur in patients who are volume and / or sodium depleted by vigorous diuretic therapy , dietary salt restriction , diarrhoea , or vomiting .
85 1 .
4 .
following intravenous administration , the mean plasma clearance is approximately 9 l / h .
